Uptrend on the daily chart: above its 50- and 200-day averages · 50-day above the 200-day · SuperTrend up since Oct 6 · above the Ichimoku cloud · RSI 56 · MACD below its signal · 9% below its 52-week high
None of the 29 investors followed here reported a position in SOMMY in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a SOMMY trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for SOMMY.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 8.4 | 17.6 | -11.7 | -1.0 | 16.5 | -11.0 | -7.9 | 17.2 | 2.1 | 1.9 | +29.6% | ||
| 2025 | -1.5 | 8.2 | 3.6 | -0.8 | -0.8 | 1.3 | 4.3 | 20.2 | 4.2 | -6.0 | 4.5 | -6.8 | +31.8% |
| 2024 | -3.1 | -14.3 | 5.4 | 0.0 | -3.7 | 5.2 | 18.4 | 13.6 | -1.6 | -6.0 | -9.7 | -9.0 | −9.4% |
| 2023 | 7.3 | -8.5 | -3.1 | -0.9 | -12.0 | 2.4 | 1.6 | -10.3 | -1.2 | -7.1 | 0.6 | -5.2 | −32.2% |
| 2022 | 6.4 | -4.7 | -4.5 | -7.7 | -2.4 | -4.9 | 0.2 | -0.1 | -13.7 | -1.1 | 7.9 | -1.2 | −24.3% |
| 2021 | 20.2 | 3.0 | 5.5 | -1.0 | 8.0 | -4.9 | -1.8 | -2.3 | 3.6 | -6.8 | -7.2 | 3.4 | +18.1% |
| 2020 | -5.7 | -18.2 | -16.6 | 5.7 | 1.2 | -4.5 | -2.6 | 12.2 | 2.0 | 1.4 | 5.2 | 12.8 | −12.0% |
| 2019 | 7.9 | -6.9 | -2.8 | 7.1 | -13.6 | 7.5 | -0.3 | -6.0 | 3.0 | 2.1 | -0.9 | -0.0 | −5.2% |
| 2018 | 2.2 | -15.5 | -6.7 | -0.3 | 3.9 | -6.3 | 3.5 | -2.5 | 3.2 | -14.8 | 8.0 | -11.6 | −33.7% |
| 2017 | 11.3 | 4.9 | 0.6 | 1.0 | -7.6 | 10.4 | 2.1 | 2.0 | 4.3 | 12.9 | -0.6 | 2.5 | +51.3% |
| 2016 | -12.0 | -13.1 | 2.9 | -2.2 | 2.1 | -10.2 | 6.9 | 4.9 | -2.8 | 6.3 | -1.4 | 2.7 | −17.2% |
| 2015 | 2.6 | 14.0 | 11.9 | 11.8 | 1.5 | 3.5 | -5.6 | -12.8 | 1.6 | 14.8 | -1.0 | 0.3 | +46.4% |
| 2014 | 9.1 | -5.7 | -10.3 | 4.0 | 0.7 | -1.1 | 1.3 | -6.2 | -0.8 | -4.4 | 3.8 | 12.0 | +0.1% |
| 2013 | -6.9 | 2.2 | 5.3 | 8.1 | -6.5 | -0.1 | 5.2 | 8.0 | 5.2 | -4.1 | 10.7 | -2.2 | +25.3% |
| 2012 | 11.9 | 8.4 | -3.3 | -3.6 | -22.6 | -1.5 | -10.0 | -5.6 | -4.2 | 10.6 | 3.3 | 8.6 | −13.1% |
| 2011 | 4.7 | 3.1 | -7.3 | 7.1 | -6.8 | 0.5 | 1.8 | -17.8 | -8.0 | -2.1 | 2.5 | -5.7 | −27.0% |
| 2010 | -15.2 | -4.2 | 11.1 | -5.5 | 6.5 | -0.3 | -1.8 | 16.1 | +3.3% |
No analyst coverage for this instrument.
Sumitomo Chemical Company, Limited engages in Agro & Life Solutions, ICT & Mobility Solutions, Advanced Medical Solutions, Essential & Green Materials, and Sumitomo Pharma. The Agro & Life Solutions segment offers crop protection chemicals, fertilizers, agricultural materials, household insecticides, products for control of infectious diseases, and feed additives, etc. The ICT & Mobility Solutions segment provides optical products, semiconductor processing materials, compound semiconductor materials, touch screen sensor panels, high-purity aluminum and alumina, specialty chemicals, additives, engineering plastics, and battery materials, etc. The Advanced Medical Solutions segment offers contract development and manufacturing organization business for small-molecule active ingredients and intermediates, oligonucleic acid drug substances, and regenerative medicine, and cell therapy products, etc. The Essential & Green Materials segment offers synthetic resins, raw materials for synthetic fibers, various industrial chemicals, methyl methacrylate products, industrial aluminum and alumina, and synthetic rubber, etc. The Sumitomo Pharma segment offers small molecule pharmaceuticals. Additionally, the company engages in the manufacture and sale of positive electrode materials for rechargeable batteries. Sumitomo Chemical Company, Limited was founded in 1913 and is headquartered in Tokyo, Japan.